Wang, F., Wang, D., Sun, L., Wang, S. (2026). Optimal subsequent-line strategies for
                    <i>EGFR</i>
                    -mutant NSCLC after TKI progression: A systematic review and network meta-analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e20506